Get more insights on Myomectomy Market
Global Myomectomy Market Is Projected To Driven By Rising Incidence Of Uterine Fibroids
The Global Myomectomy Market involves surgical procedures for removing uterine fibroids without removing the uterus. Myomectomy is one of the most common gynecological surgeries performed to treat symptomatic uterine fibroids. It helps relieve symptoms such as heavy bleeding, pain, and pressure or enlargement of the abdomen. The procedure is usually performed using minimally invasive techniques such as hysteroscopic, laparoscopic, and robotic myomectomy which offer benefits over open surgery such as less blood loss, shorter hospital stays, quicker recovery times, and smaller incisions.
The Global Myomectomy Market is estimated to be valued at US$ 791.2 MN in 2024 and is expected to exhibit a CAGR of 9.2% over the forecast period from 2024 to 2031.
The growing prevalence of uterine fibroids among women is a key factor contributing to the Myomectomy Market Growth. According to studies, over 70% of women experience uterine fibroids by the age of 50. Factors such as obesity, delayed childbearing, and past use of hormonal contraceptives increase the risk of developing fibroids.
Key Takeaways
Key players operating in the Global Myomectomy Market are Medtronic, Stryker Corporation, CONMED Corporation, CooperSurgical Inc., Ethicon, Inc., Hologic, Inc., Minerva Surgical, Inc., INSIGHTEC, Karl Storz GmbH, Intuitive Surgical, and B. Braun Melsungen AG. These players are focusing on developing advanced surgical technologies and robotic platforms for minimally invasive uterine fibroid removal procedures.
The growing demand for minimally invasive treatment alternatives for symptomatic uterine fibroids is positively impacting the market. Laparoscopic and robotic myomectomy procedures offer several advantages over open surgery and are becoming increasingly popular. This is increasing the demand for specialized devices and equipment required for minimally invasive procedures.
The rising awareness about uterine fibroid treatment options is driving the global expansion of the myomectomy market. Market players are focusing on emerging countries in Asia Pacific and Latin America through acquisitions and partnerships with local players. Population growth and economic development in these regions are expected to contribute significantly to the market in the coming years.
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian